Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2023; 15(01): 097-105
DOI: 10.1055/s-0042-1757412
Original Article

Emerging Bacterial Pathogens in the COVID-19 Era: Chryseobacterium gleum—A Case in Point

Archana Angrup   *
1   Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Bhawna Sharma    *
1   Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Inderpaul Singh Sehgal 
2   Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Manisha Biswal
1   Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Pallab Ray
1   Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Introduction In the ongoing severe acute respiratory syndrome coronavirus 2 pandemic, a long hospital stay and empirical broad-spectrum antibiotics make the patients prone to acquire nosocomial infections especially with unconventional organisms, and Chryseobacterium gleum is one such rare nosocomial pathogen.

Methods The given study is a case-series-based study conducted from September 2020 to April 2021 in which clinically suspected pneumonia patients who recovered from coronavirus disease 2019 (COVID-19) were included.

Results Seventeen C. gleum isolates were obtained in pure culture from the tracheal aspirates of nine COVID-19 patients (including repeat samples to rule out colonization) within a period of eight months (September 2020–April 2021). Our records showed that there has been an increase in the number of isolates of C. gleum obtained in respiratory samples in 2020. We also did a review of literature of all the cases of C. gleum pneumonia reported till now.

Conclusion To the best of our knowledge, this is the first study reporting the isolation of this rare pathogen from COVID-19 patients with clinical significance in a large cohort of patients. Therefore, it becomes important to consider this pathogen as a significant cause of respiratory infections, especially in patients recovered post COVID-19.

Keywords

emerging - bacterial - COVID-19 - Chryseobacterium gleum - pneumonia

Ethical Approval

The study was approved by the Institute Ethics Committee with reference no. NK/6623/Study/057.


* Archana Angrup and Bhawna Sharma are co-first authors.




Publication History

Article published online:
26 October 2022

© 2022. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Bernardet JF, Nakagawa Y, Holmes B. Subcommittee On The Taxonomy Of Flavobacterium And Cytophaga-Like Bacteria Of The International Committee On Systematics Of Prokaryotes. Proposed minimal standards for describing new taxa of the family Flavobacteriaceae and emended description of the family. Int J Syst Evol Microbiol 2002; 52 (Pt 3): 1049-1070
    PubMedGoogle Scholar
  • 2 Chiu CW, Li MC, Ko WC. et al. Clinical impact of Gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department. J Microbiol Immunol Infect 2015; 48 (01) 92-100
    CrossrefPubMedGoogle Scholar
  • 3 Virok DP, Ábrók M, Szél B. et al. Chryseobacterium gleum - a novel bacterium species detected in neonatal respiratory tract infections. J Matern Fetal Neonatal Med 2014; 27 (18) 1926-1929
    CrossrefPubMedGoogle Scholar
  • 4 Christakis GB, Perlorentzou SP, Chalkiopoulou I, Athanasiou A, Legakis NJ. Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor. J Clin Microbiol 2005; 43 (04) 2021-2023
    CrossrefPubMedGoogle Scholar
  • 5 Garg S, Appannanavar SB, Mohan B, Taneja N. Pyonephrosis due to Chryseobacterium gleum: a first case report. Indian J Med Microbiol 2015; 33 (02) 311-313
    CrossrefPubMedGoogle Scholar
  • 6 Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004; 42 (01) 445-448
    CrossrefPubMedGoogle Scholar
  • 7 Jain V, Hussain NAFA, Siddiqui T, Sahu C, Ghar M, Prasad KN. Simultaneous isolation of Chryseobacterium gleum from bloodstream and respiratory tract: first case report from India. JMM Case Rep 2017; 4 (10) e005122
    CrossrefPubMedGoogle Scholar
  • 8 Lo HH, Chang SM. Identification, characterization, and biofilm formation of clinical Chryseobacterium gleum isolates. Diagn Microbiol Infect Dis 2014; 79 (03) 298-302
    CrossrefPubMedGoogle Scholar
  • 9 Brkic DV, Zlopaša O, Bedenic B, Plecko V. Chryseobacterium gleum infection in patient with extreme malnutrition and hepatic lesion-case report. Signa Vitae 2015; 10: 50-52
    CrossrefGoogle Scholar
  • 10 Ramya TG, Baby S, Das P, Geetha RK. Chryseobacterium gleum urinary tract infection. Genes Rev 2015; 1: 1-5
    CrossrefGoogle Scholar
  • 11 Holmes B, Owen RJ, Steigerwalt AG, Brenner DJ. Flavobacterium gleum, a new species found in human clinical specimens. Int J Syst Bacteriol 1984; 34 (01) 21-25
    CrossrefGoogle Scholar
  • 12 CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 30th edition. CLSI supplement M100. Wayne: Clinical and Laboratory Standards Institute; 2020
    Google Scholar
  • 13 Ludwig W, Euzeby J, Whitman WB. Road map of the phyla Bacteroidetes, Spirochaetes, Tenericutes (Mollicutes), Acidobacteria, Fibrobacteres, Fusobacteria, Dictyoglomi, Gemmatimonadetes, Lentisphaerae, Verrucomicrobia, Chlamydiae, and Planctomycetes. In: Krieg N, Parte A, Ludwig W, Whitman W, Hedlund B, Paster B, et al., eds. Bergey's Manual of Systematic Bacteriology. Vol. 4. New York: Springer Science & Business Media; 2011: 1-19
    Google Scholar
  • 14 Hsueh PR, Hsiue TR, Wu JJ. et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 1996; 23 (03) 550-555
    CrossrefPubMedGoogle Scholar
  • 15 Lin JN, Lai CH, Yang CH, Huang YH. Differences in clinical manifestations, antimicrobial susceptibility patterns, and mutations of fluoroquinolone target genes between Chryseobacterium gleum and Chryseobacterium indologenes . Antimicrob Agents Chemother 2019; 63 (05) e02256-e18
    PubMedGoogle Scholar
  • 16 Bellais S, Poirel L, Leotard S, Naas T, Nordmann P. Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob Agents Chemother 2000; 44 (11) 3028-3034
    CrossrefPubMedGoogle Scholar
  • 17 Rajendran P, Muthusamy S, Balaji VK, Rakesh GJ, Easow JM. Urinary tract infection due to Chryseobacterium gleum, an uncommon pathogen. Indian J Pathol Microbiol 2016; 59 (04) 551-553
    CrossrefPubMedGoogle Scholar
  • 18 AbdulWahab A, Taj-Aldeen SJ, Ibrahim EB, Talaq E, Abu-Madi M, Fotedar R. Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis. Infect Drug Resist 2015; 8: 83-88
    CrossrefPubMedGoogle Scholar
  • 19 Abdalhamid B, Elhadi N, Alsamman K, Aljindan R. Chryseobacterium gleum pneumonia in an infant with nephrotic syndrome. IDCases 2016; 5: 34-36
    CrossrefPubMedGoogle Scholar
  • 20 Rawat A, Vignesh P, Sharma A. et al. Infection profile in chronic granulomatous disease: a 23-year experience from a tertiary care center in North India. J Clin Immunol 2017; 37 (03) 319-328
    CrossrefPubMedGoogle Scholar
  • 21 Mirza HC, Tuncer Ö, Ölmez S. et al. Clinical Strains of Chryseobacterium and Elizabethkingia spp. Isolated from pediatric patients in a university hospital: performance of MALDI-TOF MS-Based identification, antimicrobial susceptibilities, and baseline patient characteristics. Microb Drug Resist 2018; 24 (06) 816-821
    CrossrefPubMedGoogle Scholar
  • 22 Kaur H, Mohan B, Hallur V. et al. Increased recognition of Chryseobacterium species as an emerging cause of nosocomial urinary tract infection following introduction of matrix-assisted laser desorption/ionisation-time of flight for bacterial identification. Indian J Med Microbiol 2017; 35 (04) 610-616
    CrossrefPubMedGoogle Scholar
  • 23 Yadav VS, Das BK, Mohapatra S. et al. Clinical correlation and antimicrobial susceptibility pattern of Chryseobacterium spp.: a three year prospective study. Intractable Rare Dis Res 2021; 10 (01) 37-41
    CrossrefPubMedGoogle Scholar
  • 24 Singhal L, Gupta V, Mehta V, Singla N, Janmeja AK, Chander J. Sepsis due to Chryseobacterium gleum in a diabetic patient with chronic obstructive pulmonary disease: a case report and mini review. Jpn J Infect Dis 2017; 70 (06) 687-688
    CrossrefPubMedGoogle Scholar
  • 25 Lambiase A, Del Pezzo M, Raia V, Sepe A, Ferri P, Rossano F. Chryseobacterium respiratory tract infections in patients with cystic fibrosis. J Infect 2007; 55 (06) 518-523
    CrossrefPubMedGoogle Scholar
  • 26 Arouna O, Deluca F, Camara M. et al. Chryseobacterium gleum in a man with prostatectomy in Senegal: a case report and review of the literature. J Med Case Reports 2017; 11 (01) 118
    CrossrefPubMedGoogle Scholar
  • 27 Amisha F, Fugere T, Caceres J, Rico Crescencio JC, Falls N. Chryseobacterium gleum causing healthcare-associated pneumonia in an adult male with diffuse large B cell lymphoma. Cureus 2021; 13 (11) e19297
    PubMedGoogle Scholar
  • 28 Tsouvalas CP, Mousa G, Lee AH, Philip JA, Levine D. Chryseobacterium gleum isolation from respiratory culture following community-acquired pneumonia. Am J Case Rep 2020; 21: e921172
    CrossrefPubMedGoogle Scholar
  • 29 Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 1997; 76 (01) 30-41
    CrossrefPubMedGoogle Scholar
  • 30 Khurana S, Singh P, Sharad N. et al. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: implication on antimicrobial resistance. Indian J Med Microbiol 2021; 39 (02) 147-153
    CrossrefPubMedGoogle Scholar
  • 31 Li J, Wang J, Yang Y. et al. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control 2020; 9 (01) 153
    CrossrefPubMedGoogle Scholar
  • 32 Sharifipour E, Shams S, Esmkhani M. et al. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis 2020; 20 (01) 646
    CrossrefPubMedGoogle Scholar
  • 33 Martin H, Danila S, Agostinho C. et al. The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries. (May 12, 2021). Accessed July 10, 2022 at SSRN: https://ssrn.com/abstract=3844587 or http://dx.doi.org/10.2139/ssrn.3844587
    CrossrefGoogle Scholar
  • 34 Bengoechea JA, Bamford CGG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?. EMBO Mol Med 2020; 12 (07) e12560
    CrossrefPubMedGoogle Scholar
  • 35 Manna S, Baindara P, Mandal SM. Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2. J Infect Public Health 2020; 13 (10) 1397-1404
    CrossrefPubMedGoogle Scholar
  • 36 Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis 2011; 52 (Suppl 4): S296-S304
    CrossrefPubMedGoogle Scholar
  • 37 Hsueh PR, Teng LJ, Ho SW, Hsieh WC, Luh KT. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol 1996; 34 (08) 1908-1913
    CrossrefPubMedGoogle Scholar